Growth Metrics

Novartis Ag (NVS) Property, Plant & Equipment (Net) (2009 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn - -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn 26.54 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn 23.27 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn 5.69 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn 25.43 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn 8.22 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn 5.64 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn 19.40 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn 7.66 Bn
10 Gsk 88.34 Bn 83.66 Bn - 12.40 Bn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 10.78 Bn
Dec 31, 2025 10.78 Bn
Dec 31, 2024 9.46 Bn
Dec 31, 2024 9.46 Bn
Dec 31, 2023 9.51 Bn
Dec 31, 2023 9.51 Bn
Dec 31, 2022 10.76 Bn
Dec 31, 2022 10.76 Bn
Dec 31, 2021 11.55 Bn
Dec 31, 2021 11.55 Bn
Dec 31, 2020 12.26 Bn
Dec 31, 2020 12.26 Bn
Dec 31, 2019 -60.00 Mn
Dec 31, 2019 -60.00 Mn
Dec 31, 2018 -6.33 Bn
Dec 31, 2018 -6.33 Bn
Sep 30, 2018 141.00 Mn
Sep 30, 2018 141.00 Mn
Dec 31, 2017 -38.00 Mn
Dec 31, 2017 -38.00 Mn
Dec 31, 2016 -5.44 Bn
Dec 31, 2016 -5.44 Bn
Jun 30, 2015 8.00
Jun 30, 2015 8.00
Mar 31, 2015 8.00
Mar 31, 2015 8.00
Dec 31, 2013 145.00
Dec 31, 2013 145.00
Jun 30, 2010 -2.00
Jun 30, 2010 -2.00
Mar 31, 2010 -4.00
Mar 31, 2010 -4.00
Dec 31, 2009 14.08 Bn
Dec 31, 2009 14.08 Bn
Sep 30, 2009 13,870.00
Sep 30, 2009 13,870.00
Jun 30, 2009 -5.00
Jun 30, 2009 -5.00
Mar 31, 2009 3.00
Mar 31, 2009 3.00